| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.097 | 0.7 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |